indoleamine-2,3-dioxygenase-1 inhibitors (Merck & Co)

N/A

Report date: 2025/06/11 11:08:41
NME

Base Information

Drug Nameindoleamine-2,3-dioxygenase-1 inhibitors (Merck & Co)
Drug Alias NameIDO checkpoint inhibitor (Merck & Co)IDO-1 checkpoint inhibitor (Merck & Co)IDO1 inhibitors (Merck & Co)L-689L-765
ClassificationSmall molecules
Mechanisms of ActionT lymphocytes stimulantsIndoleamine 2,3-dioxygenase inhibitorsImmunostimulants
TargetsIndoleamine 2,3-dioxygenase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A